Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1098 | 1037 | 1165 | 1158 | 1670 | 2088 |
| Fund Return | 9.76% | 3.67% | 16.49% | 5.01% | 10.79% | 7.64% |
| Place in category | 49 | 39 | 40 | 70 | 62 | 24 |
| % in Category | 42 | 33 | 39 | 60 | 56 | 35 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Rydex NASDAQ-100 Inv | 2.01B | 8.50 | 26.92 | 19.78 | ||
| Rydex Variable NASDAQ 100 2x Strate | 153.11M | -3.44 | 27.04 | 26.20 | ||
| Rydex Variable NASDAQ 100 | 140.67M | 2.10 | 11.82 | 16.98 | ||
| Rydex S&P 500 H | 164.66M | 1.30 | 19.11 | 13.62 | ||
| Rydex Biotechnology Inv | 92.82M | 2.11 | 11.18 | 8.68 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| T. Rowe Price New Era I | 1.91B | 24.47 | 16.14 | 9.24 | ||
| Vanguard Materials Index Adm | 1.46B | 12.36 | 11.46 | 10.40 | ||
| GMO Resources IV | 1.32B | 34.03 | 10.95 | 12.65 | ||
| Aegis Value | 1.34B | 20.74 | 32.45 | 19.95 | ||
| T. Rowe Price New Era | 1.29B | 24.38 | 15.91 | 9.07 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Linde PLC | IE000S9YS762 | 4.39 | 445.600 | +0.50% | |
| Sherwin-Williams | US8243481061 | 2.70 | 309.08 | -0.08% | |
| Air Products | US0091581068 | 2.67 | 289.47 | -0.25% | |
| CRH ADR | IE0001827041 | 2.53 | 100.37 | -0.65% | |
| Freeport-McMoran | US35671D8570 | 2.46 | 61.99 | -0.51% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review